Preliminary findings are positive, but farmers must stay vigilant in farm biosecurity practices and NAIT record keeping.

A discussion document provided for a review of the act and considered Fonterra's role in the New Zealand dairy industry.

NZ has a first-class regulatory regime for food safety, as seen in the inquiry into Fonterra's Whey Protein Concentrate.

Although reform looks to be off the table, you should still stay alert & take care when advertising therapeutic products.

New Zealand's current Patents Act 1953 does not provide for a pharmaceutical extension of term – nor is such an extension proposed in the new Patents Bill 2008 which is presently before Parliament. However, with a US-NZ Free Trade Agreement imminent, things may be about to change.

Pharmac is consulting on its proposed framework and for its new roles in funding hospital medicines and medical devices.

Following the 2017 New Zealand general election, a minority coalition government has been formed between the Labour Party (Labour) and the New Zealand First Party ...

There is growing awareness amongst regulators regarding the susceptibility of children and other impressionable audiences to certain types of advertising.

Manuka honey has seen great success both domestically in New Zealand and as an export product. With this success, topical legal issues have arisen.

New Zealand became the first nation to officially legalise pill testing, or drug checking services, on 1 December 2021.

Discussion of factors that lead to doping scandals and steps to prevent them including selection of appropriate directors. .

A Government inquiry into the whey protein concentrate contamination incident (the Fonterra Inquiry) has commenced.

if your invention gives you a commercial advantage, you should consider patent rights to leverage this advantage.

Traditional Swiss-style claims provide a unique form of protection for pharmaceutical patentees against the authorised use of an active agent in the manufacture of a medicament for...